The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
136 - 177 jobs Number of planned job losses
Announcement Date
2 March 2007
Employment effect (start)
Foreseen end date
31 December 2007
Description
Bayer, the pharmaceutical manufacturer, announced on 2 March 2007 a world reorganisation plan following its merger with the Schering group. On 3 March 2007 Bayer & Shering France announced that before the end of 2007 the company would cut 136 to 177 jobs in France, nearly 20% of its workforce in the country.
Sources
4 March 2007: Le Monde
5 March 2007: La Tribune
5 March 2007: Les Echos
Citation
Eurofound (2007), Bayer & Shering, Merger/Acquisition in France, factsheet number 65045, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/65045.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
